Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors | ACS Applied Materials & Interfaces
![PCA3 Score vs PSA Free/Total Accuracy in Prostate Cancer Diagnosis at Repeat Saturation Biopsy | Anticancer Research PCA3 Score vs PSA Free/Total Accuracy in Prostate Cancer Diagnosis at Repeat Saturation Biopsy | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/31/12/4445/F1.large.jpg)
PCA3 Score vs PSA Free/Total Accuracy in Prostate Cancer Diagnosis at Repeat Saturation Biopsy | Anticancer Research
![Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts | eLife Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts | eLife](https://iiif.elifesciences.org/lax:81929%2Felife-81929-fig4-v3.tif/full/1500,/0/default.jpg)
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts | eLife
![Performance of Prostate Cancer Antigen 3 (PCA3) and Prostate-Specific Antigen in Prescreened Men: Reproducibility and Detection Characteristics for Prostate Cancer Patients with High PCA3 Scores (≥100) - ScienceDirect Performance of Prostate Cancer Antigen 3 (PCA3) and Prostate-Specific Antigen in Prescreened Men: Reproducibility and Detection Characteristics for Prostate Cancer Patients with High PCA3 Scores (≥100) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283810008948-gr1.jpg)
Performance of Prostate Cancer Antigen 3 (PCA3) and Prostate-Specific Antigen in Prescreened Men: Reproducibility and Detection Characteristics for Prostate Cancer Patients with High PCA3 Scores (≥100) - ScienceDirect
![Eng | Free Full-Text | Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer Eng | Free Full-Text | Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer](https://www.mdpi.com/eng/eng-04-00022/article_deploy/html/images/eng-04-00022-g001.png)
Eng | Free Full-Text | Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer
![Chemosensors | Free Full-Text | Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific RNA-Based Aptamer Labelled with Ferrocene Chemosensors | Free Full-Text | Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific RNA-Based Aptamer Labelled with Ferrocene](https://www.mdpi.com/chemosensors/chemosensors-09-00059/article_deploy/html/images/chemosensors-09-00059-g001.png)
Chemosensors | Free Full-Text | Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific RNA-Based Aptamer Labelled with Ferrocene
![PROGENSA PCA3 Assay Approved to Help Determine if Repeat Prostate Biopsy is Warranted - Cancer Therapy Advisor PROGENSA PCA3 Assay Approved to Help Determine if Repeat Prostate Biopsy is Warranted - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/20120215123113enprnprn-gen-pro_230564.jpg)
PROGENSA PCA3 Assay Approved to Help Determine if Repeat Prostate Biopsy is Warranted - Cancer Therapy Advisor
![PCA3: a gene-based test to help deciding if biopsy is really needed. Performed in Hill Clinic - Private clinic Hill Clinic PCA3: a gene-based test to help deciding if biopsy is really needed. Performed in Hill Clinic - Private clinic Hill Clinic](https://hillclinic.com/en/wp-content/uploads/sites/6/2013/10/d600_1431.jpg)
PCA3: a gene-based test to help deciding if biopsy is really needed. Performed in Hill Clinic - Private clinic Hill Clinic
![Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer? | Journal of Clinical Oncology Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer? | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2014/jco.2014.57.32.issue-36/jco.2013.52.8505/20161107/images/medium/zlj03614-4858-t04.jpeg)
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer? | Journal of Clinical Oncology
![LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling - ScienceDirect LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378427421001387-ga1.jpg)